Chutes & Ladders—Frontier Medicines launches with biotech vet as CEO - FierceBiotech

Chutes & Ladders—Frontier Medicines launches with biotech vet as CEO  FierceBiotechFrontier Medicines is launching with $67 million and a biotech vet as CEO; after being snapped up by Alexion, Syntimmune's CEO is joining MorphoSys; and ...